Literature DB >> 3554094

Acanthosis nigricans.

H O Sedano, R J Gorlin.   

Abstract

Acanthosis nigricans (AN) is a well-defined skin disorder characterized by velvety hyperkeratotic macules that can be accompanied by various degrees of pigmentation. Other manifestations of AN are marked papillomatous growths and deep skin markings. These changes can affect the entire skin but preferentially are observed in the axilla, neck, genitals, and oral cavity. The presence of AN around and within the oral cavity as well as its well-known association with internal malignant conditions, especially adenocarcinoma of the stomach, and/or its association with insulin resistance, has prompted this review article, which emphasizes the oral manifestations of AN.

Entities:  

Mesh:

Year:  1987        PMID: 3554094     DOI: 10.1016/0030-4220(87)90259-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  4 in total

1.  The co-occurrence of obesity, elevated blood pressure, and acanthosis nigricans among American Indian school children: identifying individual heritage and environment-level correlates.

Authors:  Mary O Hearst; Melissa N Laska; John H Himes; Mark Butterbrodt; Alan Sinaiko; Richard Iron Cloud; Mary Tobacco; Mary Story
Journal:  Am J Hum Biol       Date:  2011-03-28       Impact factor: 1.937

2.  Oral malignant acanthosis nigricans associated with endometrial adenocarcinoma.

Authors:  Han-Wen Chu; Jing-Min Li; Guan-Fu Chen; Jing-Yuan Ma
Journal:  Int J Oral Sci       Date:  2014-01-10       Impact factor: 6.344

3.  Acanthosis nigricans associated with an adrenocortical tumor in a pediatric patient.

Authors:  Elizabeth Isaacoff; Filippina Filia Dimitriadi; Frank Barrows; Bruce Pawel; Peter Mattei; Sogol Mostoufi-Moab
Journal:  Case Rep Endocrinol       Date:  2013-05-30

4.  Co-occurrence of acanthosis nigricans and bladder adenocarcinoma - case report.

Authors:  Karolina Olek-Hrab; Wojciech Silny; Ryszard Zaba; Agnieszka Osmola-Mańkowska; Małgorzata Mackiewicz-Wysocka; Aleksandra Dańczak-Pazdrowska
Journal:  Contemp Oncol (Pozn)       Date:  2013-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.